Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00732420
Show Display Options
Rank Status Study
1 Completed Open-label Study of Topotecan and Pazopanib in Advanced Solid Tumors
Condition: Solid Tumours
Interventions: Drug: topotecan;   Drug: pazopanib

Indicates status has not been verified in more than two years